ANZEF Grant Round 2025 Recipient

Reducing treatment hesitancy in Māori and Pacific Peoples with keratoconus

Led by Drs Isabella Cheung, Akilesh Gokul, Mo Ziaei and Tiwini Hemi, and Esmeralda Lo Tam, The University of Auckland

Funding amount: AUD $50,000

Keratoconus (KC) is an eye condition that can lead to severe vision loss. It affects Māori and Pacific Peoples more often and more severely than other groups. A treatment called corneal crosslinking (CXL) can stop KC from getting worse, but many patients miss their appointments. These delays can cause preventable blindness, especially for Māori patients.

This project will work with Māori and Pacific patients and their families to understand the beliefs and clinical factors that contribute to hesitancy or nonattendance for CXL. Surveys and patient records will be used to identify key contributing factors and opportunities for improvement.

Reducing treatment hesitancy in Māori and Pacific Peoples with keratoconus

Pictured: Dr Isabella Cheung

The findings will help improve communication and clinical practice, reduce treatment delays, and increase uptake of CXL. Ultimately, this research will protect sight, promote equity in eye care, and deliver benefits not only in Aotearoa New Zealand but also in Australia and the Pacific.

Funding from ANZEF will support research into the factors contributing to CXL hesitancy and non-attendance among Māori and Pacific patients. Insights from surveys and clinical records will guide updates to patient information and consultation approaches, with resources translated into multiple Pacific languages and Te Reo Māori to improve accessibility and health literacy.